ABT-072: Clinical Trials

8 completed. 5 Phase 1, 3 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	5	Completed 5
Phase 2	3	Completed 3

Follow ABT-072: new trials by email Literature Review of ABT-072 trials Research Report on ABT-072

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV) ABT-450, ABT-072, Ribavirin - Hepatitis C, HCV	Phase 2	Completed	AbbVie (prior sponsor, Abbott)	11	2010-10-01	2015-01-08
A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults ABT-072, Placebo - Hepatitis C	Phase 1	Completed	Abbott	24	2010-03-01	2010-10-25
A Randomized Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072 ABT-450, ABT-072, ABT-333 - Hepatitis C, HCV	Phase 2	Completed	AbbVie (prior sponsor, Abbott)	74	2010-03-01	2015-01-08
Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Food on the Pharmacokinetics of ABT-072 ABT-072, Placebo - Hepatitis C	Phase 1	Completed	Abbott	52	2009-09-01	2010-10-21
Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compared to ABT-072 Capsule Formulation ABT-072 - Hepatitis C	Phase 1	Completed	Abbott	18	2009-07-01	2010-10-21
A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis C ABT-072, ketoconazole, Placebo - HCV Infection	Phase 1	Completed	Abbott	32	2009-04-01	2010-10-21
A Follow-up Study to Assess Resistance to ABT-072 in HCV-infected Subjects Administered ABT-072 in Prior ABT-072 Studies ABT-072 - Hepatitis C Virus Infection	Phase 2	Completed	AbbVie (prior sponsor, Abbott)	5	2009-04-01	2013-04-01
A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults ABT-072, placebo - Hepatitis C	Phase 1	Completed	Abbott	100	2008-09-01	2010-10-21

Conditions studied

Hepatitis C (8)

Sponsors

Abbott (5)  ·  AbbVie (prior sponsor, Abbott) (3)

Countries

United States (7)  ·  Japan (1)  ·  Puerto Rico (1)

Top investigators

Daniel Cohen, MD (4)  ·  Daniel Cohen (2)  ·  Kazuko Kobayashi (1)

Results publications

PMID 23439262, PMID 25451053